Viewing Study NCT07014150

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:03 PM
Ignite Modification Date: 2026-01-19 @ 9:21 PM
Study NCT ID: NCT07014150
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-10
First Post: 2025-05-29
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Neoadjuvant Therapy of iIparomlimab and Tuvonralimab Combined With Lenvatinib for Hepatocellular Carcinoma
Sponsor: Peking Union Medical College Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma Resectable View
Keywords:

Keywords

Keyword Brief Keyword Text View
None iIparomlimab and Tuvonralimab View
None lenvatinib View
None neoadjuvant therapy View
None high-risk recurrence View
None hepatocellular carcinoma View